Skip to main content
. 2011 Feb 1;5:139–146. doi: 10.2147/OPTH.S15783

Figure 6.

Figure 6

Mean change from baseline BVCA in patients with macular edema secondary to central retinal vein occlusion or branch retinal vein occlusion who participated in the Phase III trials.

Notes: aP ≤ 0.006 compared to sham.

Abbreviations: DEX, dexamethasone; BVCA, best corrected visual acuity.